Business
Stryve Foods, Inc. Announces Preliminary FY 2024 Financials and Filing of Form 12b-25 to Extend Time to File FY 2024 Annual Report
Full Year ‘24 Net Sales of $21.0 Million Up 18.5% Year-over-YearAdjusted EBITDA Loss Improved by 32.4% Versus Prior YearSignificant Balance Sheet Transformation Underway in 2025 PLANO, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Stryve Foods, Inc. (OTC: SNAX) (“Stryve” or the “Company”), a leader in high-protein, better-for-you snacking, today unaudited preliminary Q4 2024 financial information and disclosed it had filed form 12b-25 for their Form 10K for the fiscal year ended December 31, 2024. F
About this update from Stryve Foods, Inc.
[{"type":"image","alt":"Stryve Foods, Inc.","displaySize":"","headline":null,"caption":"Stryve Foods, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":145,"url":"https://media.zenfs.com/en/globenewswire.com/89598f439205a8030b22fda84cb96cf9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KcK6stjthyUpbcD3jh.FvQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIwMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/89598f439205a8030b22fda84cb96cf9","width":300,"height":145}},"lazy":false},{"type":"text","content":"Full Year ‘24 Net Sales of $21.0 Million Up 18.5% Year-over-YearAdjusted EBITDA Loss Improved by 32.4% Versus Prior YearSignificant Balance Sheet Transformation Underway in 2025","length":179,"tagName":"p"},{"type":"text","content":"PLANO, Texas, April 01, 2025 (GLOBE NEWSWIRE) -- Stryve Foods, Inc. (OTC: SNAX) (“Stryve” or the “Company”), a leader in high-protein, better-for-you snacking, today unaudited preliminary Q4 2024 financial information and disclosed it had filed form 12b-25 for their Form 10K for the fiscal year ended December 31, 2024.","length":330,"tagName":"p"},{"type":"text","content":"FY 2024 Unaudited Preliminary financial information","length":51,"tagName":"p"},{"type":"text","content":"The unaudited preliminary financial information as of and for the year ended December 31, 2024, is as follows. The Company expects net sales of $21.0 million an increase of 18.5% versus the prior year, incur an operating loss of approximately $10.6 million an improvement of 31.2% versus the prior year, and used cash in operating activities of approximately $7.9 million. These figures compare to net sales of $17.7 million, an operating loss of $15.4 million, and cash used in operating activities of $7.4 million during the year ended December 31, 2023. The Company also expects an adjusted EBITDA loss¹ of $8.0 million, which represents a 32.4% improvement compared to $11.8 million in the prior year. As of December 31, 2024, the Company had a working capital deficit of approximately $15.0 million as compared to $7.4 million as of December 31, 2023, and had approximately $16.4 million of indebtedness.","length":914,"tagName":"p"},{"type":"text","content":"In the fourth quarter of 2024, the Company achieved net sales of $4.5 million which is up 57.5% versus the same period in 2023. Additionally, the C...